Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
about
The increasing role of pharmacogenetics in the treatment of gastrointestinal cancers.5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapy.Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors.The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracil.Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib.Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects.Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.Pharmacogenomics and stomach cancer.Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU-related toxicity.Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations.How may anticancer chemotherapy with fluorouracil be individualised?The role of pharmacogenetics in cancer therapeutics.The role of drug-metabolising enzymes in clinical responses to chemotherapy.Recent progress and clinical importance on pharmacogenetics in cancer therapy.Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation.Severe colitis after administration of UFT chemotherapy for temporal bone carcinoma.Mutations in exon 14 of dihydropyrimidine dehydrogenase and 5-Fluorouracil toxicity in Portuguese colorectal cancer patients.A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity.Multiple organ failure due to 5-fluorouracil chemotherapy in a patient with a rare dihydropyrimidine dehydrogenase gene variant.Gene-Specific Variant Classifier (DPYD-Varifier) to Identify Deleterious Alleles of Dihydropyrimidine Dehydrogenase.
P2860
Q33591937-1D3EB651-5EE2-4184-B9C1-D5EE2845C0ABQ33750445-BD571D97-56CF-4FA5-A1C5-1E104F2CEA91Q34467460-10F5E66A-1F89-4BEB-8DCD-51C4211A5179Q34761260-BA1EC1FB-015B-4295-8846-E150430887CCQ35178065-CBC1A1CC-A280-40F5-84BD-612939A1DDFAQ35802542-40A6633B-CD80-4367-9384-BAC2A9598A44Q35803786-A57273DA-5710-44EF-AC6D-08D70380D0FFQ35873676-8B39464A-E400-4C71-9A09-E620D4AD9D22Q36024590-2ACFBBD1-DBF6-41E8-808F-C9B59AB21CF9Q36055251-E09A40FC-35C5-4FCF-A58E-B7B8C7154619Q36486034-81B4EB58-7C0C-46D7-96F3-A9141C35115EQ36536674-7564319F-19F9-40A0-A973-CA8E0C463723Q36545015-5F7461CD-2FCF-44AA-851C-5BC0048486EFQ37382559-D4F3262E-684F-4429-91BA-A8E0F58BF294Q44124430-09C5697D-D3B1-4D51-BF50-AF142EEAF6B2Q44790410-83831680-5C7B-4B5B-9638-40BA27EEAAA7Q44797335-9E074331-907D-4E67-BA39-799AEE76C797Q44991007-437D50A0-86E6-458B-A0B5-8D525580C172Q45183213-D105A398-1D4E-4AFF-BC2C-B7E75F0A7484Q50073098-6597F263-65F5-4327-85C3-957020182425
P2860
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
@ast
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
@en
type
label
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
@ast
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
@en
prefLabel
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
@ast
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
@en
P2093
P2860
P356
P1476
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
@en
P2093
Fernandez-Salguero P
Gonzalez FJ
P2860
P2888
P304
P356
10.1038/BJC.1998.79
P407
P577
1998-01-01T00:00:00Z
P5875
P6179
1027533598